Southern Research's Drug Discovery division conducts research focused on oncology, infectious disease, and neuroscience. Their current service areas include: High Throughput Screening (HTS), Chemistry, Oncology, Infectious Disease, Neuroscience, and the Center for Neuromolecular Research.
Southern Research is a founding member of the Alabama Drug Discovery Alliance (ADDA) along with the University of Alabama at Birmingham School of Medicine (SOM). The UAB Center for Clinical and Translational Science (CCTS), and the UAB Comprehensive Cancer Center (CCC) are also crucial contributors to the ADDA.
Mark J. Suto is vice president of Drug Discovery at Southern Research. He has been named a Fellow of the National Academy of Inventors (NAI) in recognition of his wide-ranging contributions to pharmaceutical research and drug discovery efforts.